RUBY - Rubius Therapeutics GAAP EPS of -$0.49 beats by $0.03 August, 09 2022 08:12 AM Rubius Therapeutics Inc. Rubius Therapeutics press release ( NASDAQ: RUBY ): Q2 GAAP EPS of -$0.49 beats by $0.03 . cash, cash equivalents and investments were $140.7 million For further details see: Rubius Therapeutics GAAP EPS of -$0.49 beats by $0.03